Le Monde de Francia a 300,000 lectores: los usuarios de Finasteride se cuidan

25 de enero de 2019 Queridos amigos: Francia está en eso otra vez. Hacer lo correcto, eso es. A principios de esta semana, Le Monde, el segundo periódico más grande de la nación, con una circulación diaria de más de 300,000 copias, publicó una historia titulada Cuando se lucha contra la pérdida de cabello, tenga […]

Un Estudio Clínico Sugiere que Existen ‘Anormalías Neurobiológicas Subyacentes’ en los Usuarios de Finasteride con Disfunción Sexual Permanente

SOMERSET, N.J., Sept. 29, 2016 – Men who experience persistent sexual dysfunction after discontinuing finasteride have “neurobiological abnormalities,” suggests a new study published in The Journal of Clinical Endocrinology & Metabolism. Among those abnormalities is neural circuitry that overlaps with functional abnormalities identified in men suffering from “major depression.” Titled Characteristics of Men Who Report […]

El Tráfico de la Página Web de la Fundación del SPF aumenta hasta un 33% Año tras Año

SOMERSET, N.J., Jan. 5, 2016 – Traffic to the PFS Foundation website rose 33.6 percent in 2015, compared to 2014, according to Google Analytics. Concurrently, users in 161 countries—or 82.5 percent of the world (as defined by the 195 nations recognized by the U.S. Department of State)—accessed information on the condition via PFSFoundation.org in 2015, […]

Finasterida ‘Causa Varias Alteraciones’ en la Región del Cerebro Responsable de Procesar la Memoria a Largo plazo y las Respuestas Emocionales, como un Nuevo Estudio de Modelo Animal Demuestra

SOMERSET, NJ, 1 de octubre de 2018 – “El tratamiento con finasteride causa varias alteraciones en el hipocampo,” la sección del cerebro responsable del procesamiento de la memoria a largo plazo y las respuestas emocionales, según un nuevo estudio realizado en la Universidad de Milán, y El Instituto Cajal y el Instituto de Salud Carlos […]

Discurso Anual de la Fundación SPF 2014

Aug. 4, 2014 Dear Friends: I’m pleased to report that 2014 is shaping up to be a turning point on the road to widespread awareness of post-finasteride syndrome. Couple that with the steady progress of our clinical studies and I become ever more hopeful that the coming year will bring not only worldwide acceptance of […]

Aumenta el Suicidio Inducido por Finasterida y el Comportamiento Autolesivo en un 33% en la Base de datos de Reacciones Adversas a Medicamentos de La Organización Mundial de la Salud (OMS)

SOMERSET, N.J., Jan. 5, 2016 – Reports of finasteride-induced Suicidal and Self-Injurious Behavior are up 33 percent in the World Health Organization Progamme for International Drug Monitoring’s database of adverse drug reactions (ADRs) for Q4 vs. Q3 2015. Within that category (itself a subcategory of Psychiatric Disorders), suicidal ideaton is up 47.2%; suicide attempts up […]

Estudio Clínico del Síndrome Post-Finasterida Lanzado en Brigham and Women’s Hospital

SOMERSET, N.J., July 1, 2013 – The Post-Finasteride Syndrome Foundation today announced the funding of a major clinical study on post-finasteride syndrome (PFS) at Brigham and Women’s Hospital (BWH), a teaching affiliate of Harvard Medical School. Titled “A Preliminary, Hypothesis-Generating Investigation of the Post-Finasteride Syndrome: Description of the Phenotype, and Elucidation of the Hormonal, Genetic […]

Estudio Clínico del Síndrome Post-Finasterida Lanzado en la Facultad de Medicina de Baylor

SOMERSET, N.J., Aug. 21, 2013 – The Post-Finasteride Syndrome Foundation today announced the funding of a second major clinical study on post-finasteride syndrome (PFS), this one at Baylor College of Medicine (BCM) in Houston, Texas. Titled “Genetic and Epigenetic Studies on Post-Finasteride Syndrome Patients,” the research is being led by Mohit Khera (right), MD, MBA, […]